Showing results (381-390 of 433) with videos related to

Sort By:
Pageof 44
BJOG : an International Journal of Obstetrics and Gynaecology|February 7, 2013
Trends in the prevalence, risk and pregnancy outcome of multiple births with congenital anomaly: a registry-based study in 14 European countries 1984-2007B Boyle, R McConkey, E Garne, et al.
The Canadian Journal of Cardiology|December 6, 2007
Outpatient percutaneous coronary intervention: Ready for prime time?Olivier F Bertrand, Eric Larose, Robert De Larochellière, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 22, 2008
Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterizationPhilippe Lachance, Jean-Pierre Déry, Josep Rodés-Cabau, et al.
The Canadian Journal of Cardiology|September 12, 2009
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trialOlivier F Bertrand, Paul Poirier, Josep Rodés-Cabau, et al.
The American Journal of Cardiology|July 25, 2006
Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or atypical chest painJean-Michel Potvin, Josep Rodés-Cabau, Olivier F Bertrand, et al.
The American Journal of Cardiology|August 19, 2007
Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass graftingJosep Rodés-Cabau, Alvaro Facta, Eric Larose, et al.
The Canadian Journal of Cardiology|December 6, 2007
Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung InstitutePatrick Garceau, Jean-Pierre Déry, Philippe Lachance, et al.
The American Journal of Cardiology|September 18, 2012
Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary interventionJimmy MacHaalany, Eltigani Abdelaal, Yoann Bataille, et al.
American Heart Journal|March 5, 2013
Successive transradial access for coronary procedures: experience of Quebec Heart-Lung InstituteEltigani Abdelaal, Pierre Molin, Guillaume Plourde, et al.
Atherosclerosis|July 3, 2010
Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trialOlivier F Bertrand, Paul Poirier, Josep Rodés-Cabau, et al.
Pageof 44